Physician profile
Bashar Brijawi
NPI 1033198171
$2,840.22
in general payments reported to CMS, 2019-2025
23 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $47.77 · 2021: $146 · 2022: $464 · 2023: $856 · 2024: $575 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,752 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,751.52 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $584.84 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Jazz Pharmaceuticals INC. | $500.74 | 2019-2025 | |
| Glaxosmithkline, LLC. | $327.19 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $265.14 | 2021-2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $160.25 | 2021-2023 | Glassia |
| Genzyme Corporation | $157.06 | 2021-2023 | |
| Fisher & Paykel Healthcare INC | $122.54 | 2023-2025 | Fisher & Paykel Healthcare |
| Grifols USA, LLC | $118.86 | 2023-2025 | Prolastin-C Liquid |
| Amgen INC. | $104.17 | 2019-2022 | |
| Pulmonx Corporation | $55.88 | 2022-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Resmed Corp | $54.09 | 2021-2023 | |
| Inspire Medical Systems, INC. | $53.43 | 2024-2025 | Inspire |
| Baxter Healthcare | $50.32 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $47.78 | 2022-2023 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $46.34 | 2022-2023 | Opsumit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $34.38 | 2022 | |
| Philips North America LLC | $33.73 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mylan Specialty L.P. | $33.37 | 2020-2023 | Yupelri |
| Idorsia Pharmaceuticals US INC | $26.87 | 2023 | Quviviq |
| Phadia US INC. | $18.17 | 2023 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.03 | 2023 | Ofev |
| Lilly USA, LLC | $15.71 | 2025 | Zepbound |
| Electromed, INC. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Brijawi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.